↓ Skip to main content

Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue

Overview of attention for article published in International Journal of Biochemistry & Cell Biology, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

twitter
20 tweeters
facebook
5 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
134 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue
Published in
International Journal of Biochemistry & Cell Biology, October 2014
DOI 10.1016/j.biocel.2014.08.007
Pubmed ID
Authors

Patrick McDonough, Joseph P. McKenna, Christine McCreary, Eric J. Downer

Abstract

Neuropathic orofacial pain (NOP) exists in several forms including pathologies such as burning mouth syndrome (BMS), persistent idiopathic facial pain (PIFP), trigeminal neuralgia (TN) and postherpetic neuralgia (PHN). BMS and PIFP are classically diagnosed by excluding other facial pain syndromes. TN and PHN are most often diagnosed based on a typical history and presenting pain characteristics. The pathophysiology of some of these conditions is still unclear and hence treatment options tend to vary and include a wide variety of treatments including cognitive behaviour therapy, anti-depressants, anti-convulsants and opioids; however such treatments often have limited efficacy with a great amount of inter-patient variability and poorly tolerated side effects. Analgesia is one the principal therapeutic targets of the cannabinoid system and many studies have demonstrated the efficacy of cannabinoid compounds in the treatment of neuropathic pain. This review will investigate the potential use of cannabinoids in the treatment of symptoms associated with NOP.

Twitter Demographics

The data shown below were collected from the profiles of 20 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Italy 1 <1%
Unknown 131 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 17%
Researcher 21 16%
Student > Postgraduate 14 10%
Student > Master 14 10%
Other 9 7%
Other 24 18%
Unknown 29 22%
Readers by discipline Count As %
Medicine and Dentistry 54 40%
Biochemistry, Genetics and Molecular Biology 7 5%
Psychology 7 5%
Neuroscience 5 4%
Agricultural and Biological Sciences 5 4%
Other 24 18%
Unknown 32 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 November 2018.
All research outputs
#2,129,517
of 23,517,535 outputs
Outputs from International Journal of Biochemistry & Cell Biology
#79
of 2,455 outputs
Outputs of similar age
#24,578
of 255,224 outputs
Outputs of similar age from International Journal of Biochemistry & Cell Biology
#2
of 54 outputs
Altmetric has tracked 23,517,535 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,455 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.